Free Trial
NASDAQ:ERAS

Erasca (ERAS) Stock Price, News & Analysis

Erasca logo
$2.42 +0.29 (+13.62%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$2.46 +0.04 (+1.65%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Erasca Stock (NASDAQ:ERAS)

Advanced

Key Stats

Today's Range
$2.13
$2.65
50-Day Range
$1.39
$2.42
52-Week Range
$1.01
$3.31
Volume
4.67 million shs
Average Volume
1.71 million shs
Market Capitalization
$686.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.71
Consensus Rating
Hold

Company Overview

Erasca Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

ERAS MarketRank™: 

Erasca scored higher than 50% of companies evaluated by MarketBeat, and ranked 564th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Erasca has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 5 buy ratings, 1 hold rating, and 2 sell ratings.

  • Upside Potential

    Erasca has a consensus price target of $3.71, representing about 53.5% upside from its current price of $2.42.

  • Amount of Analyst Coverage

    Erasca has only been the subject of 3 research reports in the past 90 days.

  • Read more about Erasca's stock forecast and price target.
  • Earnings Growth

    Earnings for Erasca are expected to grow in the coming year, from ($0.73) to ($0.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Erasca is -5.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Erasca is -5.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Erasca has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Erasca's valuation and earnings.
  • Percentage of Shares Shorted

    11.57% of the float of Erasca has been sold short.
  • Short Interest Ratio / Days to Cover

    Erasca has a short interest ratio ("days to cover") of 19.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Erasca has recently decreased by 0.53%, indicating that investor sentiment is improving.
  • Dividend Yield

    Erasca does not currently pay a dividend.

  • Dividend Growth

    Erasca does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.57% of the float of Erasca has been sold short.
  • Short Interest Ratio / Days to Cover

    Erasca has a short interest ratio ("days to cover") of 19.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Erasca has recently decreased by 0.53%, indicating that investor sentiment is improving.
  • News Sentiment

    Erasca has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Erasca this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for ERAS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Erasca to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Erasca insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.40% of the stock of Erasca is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    67.78% of the stock of Erasca is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Erasca's insider trading history.
Receive ERAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Erasca and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ERAS Stock News Headlines

Erasca: Hype Building Into The End Of The Year (Rating Downgrade)
Spotlight On September 2025's Promising Penny Stocks
URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
Morgan Stanley Downgrades Erasca (ERAS)
See More Headlines

ERAS Stock Analysis - Frequently Asked Questions

Erasca's stock was trading at $2.51 at the beginning of 2025. Since then, ERAS shares have decreased by 3.6% and is now trading at $2.42.

Erasca, Inc. (NASDAQ:ERAS) released its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.12) EPS for the quarter, meeting the consensus estimate of ($0.12).

Erasca (ERAS) raised $262 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 17,500,000 shares at $14.00-$16.00 per share.

Shares of ERAS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Erasca investors own include Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), American Water Works (AWK), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/12/2025
Today
10/06/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ERAS
CIK
1761918
Fax
N/A
Employees
120
Year Founded
2018

Price Target and Rating

High Price Target
$6.00
Low Price Target
$1.00
Potential Upside/Downside
+53.5%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$161.65 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-31.19%
Return on Assets
-26.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.03
Quick Ratio
11.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
1.61

Miscellaneous

Outstanding Shares
283,670,000
Free Float
242,822,000
Market Cap
$686.48 million
Optionable
Optionable
Beta
1.18

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ERAS) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners